Endogenous prolactin generated during peripheral inflammation contributes to thermal hyperalgesia

European Journal of Neuroscience

Volumn 34, Issue 5, 2011, Pages 745-754

  Scotland, Phoebe E ^a   Patil, Mayur ^a   Belugin, Sergei ^b   Henry, Michael A ^b   Goffin, Vincent ^c   Hargreaves, Kenneth M ^a,b   Akopian, Armen N ^b  

^a University of Texas Health Science Center   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c INSERM   (France)

Author keywords

Inflammation; Prolactin; Prolactin antagonist; Rat; Sensory neurons; TRPV1

Indexed keywords

CAPSAICIN; ESTRADIOL; FREUND ADJUVANT; HORMONE RECEPTOR BLOCKING AGENT; PROLACTIN; PROLACTIN RECEPTOR; PROLACTIN RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 1;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL MIGRATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG TARGETING; FEMALE; HINDLIMB; HORMONE ACTION; HORMONE BLOOD LEVEL; HORMONE RELEASE; HORMONE SUBSTITUTION; HYPERALGESIA; INFLAMMATION; MACROPHAGE ACTIVATION; MALE; MONOCYTE; NOCICEPTION; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; SENSORY NERVE CELL; SEX DIFFERENCE; STEM CELL; THERMAL HYPERALGESIA; THERMOREGULATION; TISSUE DISTRIBUTION;

ANIMALS; ESTRADIOL; FEMALE; FREUND'S ADJUVANT; HUMANS; HYPERALGESIA; INFLAMMATION; MALE; OVARIECTOMY; PATCH-CLAMP TECHNIQUES; PERIPHERAL NERVES; PROLACTIN; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PROLACTIN; SENSORY RECEPTOR CELLS; TRPV CATION CHANNELS;

EID: 80052438298     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2011.07788.x     Document Type: Article

References (60)

1. Asfaha, S., Brussee, V., Chapman, K., Zochodne, D.W. & Vergnolle, N. (2002) Proteinase-activated receptor-1 agonists attenuate nociception in response to noxious stimuli. Br. J. Pharmacol., 135, 1101-1106.
2. Ben-Jonathan, N., Mershon, J.L., Allen, D.L. & Steinmetz, R.W. (1996) Extrapituitary prolactin: distribution, regulation, functions, and clinical aspects. Endocr. Rev., 17, 639-669.
3. Ben-Jonathan, N., LaPensee, C.R. & LaPensee, E.W. (2008) What can we learn from rodents about prolactin in humans? Endocr. Rev., 29, 1-41.
4. Bernichtein, S., Kayser, C., Dillner, K., Moulin, S., Kopchick, J.J., Martial, J.A., Norstedt, G., Isaksson, O., Kelly, P.A. & Goffin, V. (2003) Development of pure prolactin receptor antagonists. J. Biol. Chem., 278, 35988-35999.
5. Bernichtein, S., Touraine, P. & Goffin, V. (2010) New concepts in prolactin biology. J. Endocrinol., 206, 1-11.
6. Bhoola, K.D., Elson, C.J. & Dieppe, P.A. (1992) Kinins - key mediators in inflammatory arthritis? Br. J. Rheumatol., 31, 509-518.
7. Bletsa, A., Berggreen, E., Fristad, I., Tenstad, O. & Wiig, H. (2006) Cytokine signalling in rat pulp interstitial fluid and transcapillary fluid exchange during lipopolysaccharide-induced acute inflammation. J. Physiol., 573, 225-236.
8. Bole-Feysot, C., Goffin, V., Edery, M., Binart, N. & Kelly, P.A. (1998) Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice. Endocr. Rev., 19, 225-268.
9. Bonnington, J.K. & McNaughton, P.A. (2003) Signalling pathways involved in the sensitisation of mouse nociceptive neurones by nerve growth factor. J. Physiol., 551, 433-446.
10. Bosco, D., Belfiore, A., Fava, A., De Rose, M., Plastino, M., Ceccotti, C., Mungari, P., Iannacchero, R. & Lavano, A. (2008) Relationship between high prolactine levels and migraine attacks in patients with microprolactinoma. J. Headache Pain, 9, 103-107.
11. Boutin, J.M., Jolicoeur, C., Okamura, H., Gagnon, J., Edery, M., Shirota, M., Banville, D., Dusanter-Fourt, I., Djiane, J. & Kelly, P.A. (1988) Cloning and expression of the rat prolactin receptor, a member of the growth hormone/prolactin receptor gene family. Cell, 53, 69-77.
12. Brand, J.M., Frohn, C., Cziupka, K., Brockmann, C., Kirchner, H. & Luhm, J. (2004) Prolactin triggers pro-inflammatory immune responses in peripheral immune cells. Eur. Cytokine Netw., 15, 99-104.
13. Brizio-Molteni, L., Molteni, A., Warpeha, R.L., Angelats, J., Lewis, N. & Fors, E.M. (1984) Prolactin, corticotropin, and gonadotropin concentrations following thermal injury in adults. J. Trauma, 24, 1-7.
14. Buckley, A.R., Crowe, P.D. & Russell, D.H. (1988) Rapid activation of protein kinase C in isolated rat liver nuclei by prolactin, a known hepatic mitogen. Proc. Natl Acad. Sci. USA, 85, 8649-8653.
15. Bueno, L. & Fioramonti, J. (2002) Visceral perception: inflammatory and non-inflammatory mediators. Gut, 51(Suppl. 1), i19-i23.
16. Caterina, M.J., Leffler, A., Malmberg, A.B., Martin, W.J., Trafton, J., Petersen-Zeitz, K.R., Koltzenburg, M., Basbaum, A.I. & Julius, D. (2000) Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science, 288, 306-313.
17. Clevenger, C.V. & Kline, J.B. (2001) Prolactin receptor signal transduction. Lupus, 10, 706-718.
18. Colao, A., Di Sarno, A., Guerra, E., De Leo, M., Mentone, A. & Lombardi, G. (2006) Drug insight: Cabergoline and bromocriptine in the treatment of hyperprolactinemia in men and women. Nat. Clin. Pract. Endocrinol. Metab., 2, 200-210.
19. Costello, A.H. & Hargreaves, K.M. (1989) Suppression of carrageenan-induced hyperalgesia, hyperthermia and edema by a bradykinin antagonist. Eur. J. Pharmacol., 171, 259-263.
20. Dagvadorj, A., Collins, S., Jomain, J.B., Abdulghani, J., Karras, J., Zellweger, T., Li, H., Nurmi, M., Alanen, K., Mirtti, T., Visakorpi, T., Bubendorf, L., Goffin, V. & Nevalainen, M.T. (2007) Autocrine prolactin promotes prostate cancer cell growth via Janus kinase-2-signal transducer and activator of transcription-5a/b signaling pathway. Endocrinology, 148, 3089-3101.
21. Davis, J.B., Gray, J., Gunthorpe, M.J., Hatcher, J.P., Davey, P.T., Overend, P., Harries, M.H., Latcham, J., Clapham, C., Atkinson, K., Hughes, S.A., Rance, K., Grau, E., Harper, A.J., Pugh, P.L., Rogers, D.C., Bingham, S., Randall, A. & Sheardown, S.A. (2000) Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia. Nature, 405, 183-187.
22. Diogenes, A., Patwardhan, A.M., Jeske, N.A., Ruparel, N.B., Goffin, V., Akopian, A.N. & Hargreaves, K.M. (2006) Prolactin modulates TRPV1 in female rat trigeminal sensory neurons. J. Neurosci., 26, 8126-8136.
23. Dugan, A.L., Malarkey, W.B., Schwemberger, S., Jauch, E.C., Ogle, C.K. & Horseman, N.D. (2004) Serum levels of prolactin, growth hormone, and cortisol in burn patients: correlations with severity of burn, serum cytokine levels, and fatality. J. Burn Care Rehabil., 25, 306-313.
24. Eyal, O., Jomain, J.B., Kessler, C., Goffin, V. & Handwerger, S. (2007) Autocrine prolactin inhibits human uterine decidualization: a novel role for prolactin. Biol. Reprod., 76, 777-783.
25. Ferreira, S.H. (1993) The role of interleukins and nitric oxide in the mediation of inflammatory pain and its control by peripheral analgesics. Drugs, 46(Suppl 1), 1-9.
26. Ferreira, S.H., Lorenzetti, B.B., Cunha, F.Q. & Poole, S. (1993a) Bradykinin release of TNF-alpha plays a key role in the development of inflammatory hyperalgesia. Agents Actions, 38(Spec No), C7-C9.
27. Ferreira, S.H., Lorenzetti, B.B. & Poole, S. (1993b) Bradykinin initiates cytokine-mediated inflammatory hyperalgesia. Br. J. Pharmacol., 110, 1227-1231.
28. Goffin, V., Bernichtein, S., Touraine, P. & Kelly, P.A. (2005) Development and potential clinical uses of human prolactin receptor antagonists. Endocr. Rev., 26, 400-422.
29. Goupille, O., Barnier, J.V., Guibert, B., Paly, J. & Djiane, J. (2000) Effect of PRL on MAPK activation: negative regulatory role of the C-terminal part of the PRL receptor. Mol. Cell. Endocrinol., 159, 133-146.
30. Guo, A., Vulchanova, L., Wang, J., Li, X. & Elde, R. (1999) Immunocytochemical localization of the vanilloid receptor 1 (VR1): relationship to neuropeptides, the P2X3 purinoceptor and IB4 binding sites. Eur. J. Neurosci., 11, 946-958.
31. Hargreaves, K.M. & Costello, A. (1990) Glucocorticoids suppress levels of immunoreactive bradykinin in inflamed tissue as evaluated by microdialysis probes. Clin. Pharmacol. Ther., 48, 168-178.
32. Hargreaves, K., Dubner, R., Brown, F., Flores, C. & Joris, J. (1988) A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain, 32, 77-88.
33. Hargreaves, K.M., Dubner, R. & Costello, A.H. (1989) Corticotropin releasing factor (CRF) has a peripheral site of action for antinociception. Eur. J. Pharmacol., 170, 275-279.
34. Henry, M.A., Freking, A.R., Johnson, L.R. & Levinson, S.R. (2006) Increased sodium channel immunofluorescence at myelinated and demyelinated sites following an inflammatory and partial axotomy lesion of the rat infraorbital nerve. Pain, 124, 222-233.
35. Hogg, R.C. & Bertrand, D. (2007) Partial agonists as therapeutic agents at neuronal nicotinic acetylcholine receptors. Biochem. Pharmacol., 73, 459-468.
36. Jacobson, E.M., Hugo, E.R., Tuttle, T.R., Papoian, R. & Ben-Jonathan, N. (2010) Unexploited therapies in breast and prostate cancer: blockade of the prolactin receptor. Trends Endocrinol. Metab., 21, 691-698.
37. Jeske, N.A., Patwardhan, A.M., Gamper, N., Price, T.J., Akopian, A.N. & Hargreaves, K.M. (2006) Cannabinoid WIN 55, 212-2 regulates TRPV1 phosphorylation in sensory neurons. J. Biol. Chem., 281, 32879-32890.
38. Ji, R.R., Samad, T.A., Jin, S.X., Schmoll, R. & Woolf, C.J. (2002) p38 MAPK activation by NGF in primary sensory neurons after inflammation increases TRPV1 levels and maintains heat hyperalgesia. Neuron, 36, 57-68.
39. Kang, S., Wu, C., Banik, R.K. & Brennan, T.J. (2010) Effect of capsaicin treatment on nociceptors in rat glabrous skin one day after plantar incision. Pain, 148, 128-140.
40. Kelly, A.M. (2001) The minimum clinically significant difference in visual analogue scale pain score does not differ with severity of pain. Emerg. Med. J., 18, 205-207.
41. Kiasalari, Z., Salehi, I., Zhong, Y., McMahon, S.B., Michael-Titus, A.T. & Michael, G.J. (2010) Identification of perineal sensory neurons activated by innocuous heat. J. Comp. Neurol., 518, 137-162.
42. Lichtman, A.H. (1998) The up-and-down method substantially reduces the number of animals required to determine antinociceptive ED50 values. J. Pharmacol. Toxicol. Methods, 40, 81-85.
43. Linley, J.E., Rose, K., Ooi, L. & Gamper, N. (2010) Understanding inflammatory pain: ion channels contributing to acute and chronic nociception. Pflugers Arch., 459, 657-669.
44. Lissoni, P., Bignami, A., Frontini, L., Manganini, V., Dapretto, E., Gardani, G.S., Vigano, P. & Strada, G. (2005) Possible involvement of prolactin in endocrine-resistant metastatic prostate cancer. Int. J. Biol. Markers, 20, 123-125.
45. Mannino, C.A., South, S.M., Inturrisi, C.E. & Quinones-Jenab, V. (2005) Pharmacokinetics and effects of 17beta-estradiol and progesterone implants in ovariectomized rats. J. Pain, 6, 809-816.
46. Manson, J.E. (2010) Pain: sex differences and implications for treatment. Metabolism, 59(Suppl 1), S16-20.
47. McMahon, S.B., Bennett, D.L.H. & Bevan, S. (2010) Inflammatory mediators and modulators of pain. In Wall, P. & Melzack, R. (eds), Textbook of Pain (online; Section 1. Neurobiology of pain. Chapter 3).
48. Pare, M., Albrecht, P.J., Noto, C.J., Bodkin, N.L., Pittenger, G.L., Schreyer, D.J., Tigno, X.T., Hansen, B.C. & Rice, F.L. (2007) Differential hypertrophy and atrophy among all types of cutaneous innervation in the glabrous skin of the monkey hand during aging and naturally occurring type 2 diabetes. J. Comp. Neurol., 501, 543-567.
49. Rowbotham, M.C. (2001) What is a "clinically meaningful" reduction in pain? Pain, 94, 131-132.
50. Sabharwal, P., Glaser, R., Lafuse, W., Varma, S., Liu, Q., Arkins, S., Kooijman, R., Kutz, L., Kelley, K.W. & Malarkey, W.B. (1992) Prolactin synthesized and secreted by human peripheral blood mononuclear cells: an autocrine growth factor for lymphoproliferation. Proc. Natl Acad. Sci. USA, 89, 7713-7716.
51. Sarter, M. & Fritschy, J.M. (2008) Reporting statistical methods and statistical results in EJN. Eur. J. Neurosci., 28, 2363-2364.
52. Schaible, H.G., Ebersberger, A. & Von Banchet, G.S. (2002) Mechanisms of pain in arthritis. Ann. NY Acad. Sci., 966, 343-354.
53. Schreyer, D.J. & Skene, J.H. (1991) Fate of GAP-43 in ascending spinal axons of DRG neurons after peripheral nerve injury: delayed accumulation and correlation with regenerative potential. J. Neurosci., 11, 3738-3751.
54. Sommer, C., Schmidt, C., George, A. & Toyka, K.V. (1997) A metalloprotease-inhibitor reduces pain associated behavior in mice with experimental neuropathy. Neurosci. Lett., 237, 45-48.
55. Wang, Y., O'Neal, K.D. & Yu-Lee, L. (1997) Multiple prolactin (PRL) receptor cytoplasmic residues and Stat1 mediate PRL signaling to the interferon regulatory factor-1 promoter. Mol. Endocrinol., 11, 1353-1364.
56. Wennbo, H. & Tornell, J. (2000) The role of prolactin and growth hormone in breast cancer. Oncogene, 19, 1072-1076.
57. Wozniak, S.E., Gee, L.L., Wachtel, M.S. & Frezza, E.E. (2009) Adipose tissue: the new endocrine organ? A review article. Dig. Dis. Sci., 54, 1847-1856.
58. Yokoyama, Y., Schwacha, M.G., Samy, T.S., Bland, K.I. & Chaudry, I.H. (2002) Gender dimorphism in immune responses following trauma and hemorrhage. Immunol. Res., 26, 63-76.
59. Yuan, Z.F. & Pan, J.T. (2002) Involvement of angiotensin II, TRH and prolactin-releasing peptide in the estrogen-induced afternoon prolactin surge in female rats: studies using antisense technology. Life Sci., 71, 899-910.
60. Zimmermann, K., Reeh, P.W. & Averbeck, B. (2002) ATP can enhance the proton-induced CGRP release through P2Y receptors and secondary PGE(2) release in isolated rat dura mater. Pain, 97, 259-265.